Materials today. Bio · ·Added 10 Nov 2026

Metal-based hydrogen-generating therapeutic systems: From reactive chemistry to route-specific exposure and translational design.

Shengwei Zhang, Weijian Fan, Zhiheng Xu, Zhiqin Zhen, Songnan Qu, Jinyun Tan

DOI ↗

Abstract

Molecular hydrogen (H2) has shown broad therapeutic relevance in oxidative injury, inflammation, metabolic dysfunction and tissue repair, yet its clinical translation remains limited by rapid diffusion, poor retention and a poorly defined dose-exposure relationship. Metal-based H2-generating systems offer an engineering strategy to produce or release H2 at pathological sites or material-tissue interfaces, where local exposure can be shaped by material design. This review reframes these platforms as material-formulation-route-indication systems rather than isolated material classes. The field now extends from classical metal hydrides to broader metal-containing platforms that generate or release H2 through hydrolysis, corrosion, electrochemical reactions or hydrogen storage-mediated release. Their therapeutic behavior is governed by route-specific exposure fields shaped by H2 release, accompanying reaction chemistry, formulation-defined compartments and tissue environments. Accordingly, route-oriented evaluation is essential because the same reactive core can produce distinct exposure profiles, safety boundaries and translational requirements across oral, local, vascular and implantable contexts. Mechanistically, H2-dependent redox and cytoprotective biology provides an important entry point, but therapeutic outcomes arise from a multi-effector local chemical milieu involving metal-derived species, coupled physicochemical changes and, in some platforms, external activation. Translational development therefore requires controlled materials engineering, route-specific exposure metrics, mechanism-matched validation, a PK/PD-like exposure-response framework adapted for reactive material systems and manufacturing strategies aligned with chemistry, manufacturing and controls (CMC) requirements. The field should advance toward route-specific, exposure-defined and mechanism-validated local reaction therapy.

Abstract as supplied by the indexing source. © the authors / publisher.